The F_EY1_Z_AH0_Z AH1_V K_L_IH1_N_AH0_K_AH0_L R_IY0_S_ER1_CH AA1_R DH_AH0 S_T_EH1_P_S IH0_N W_IH1_CH S_AY1_AH0_N_T_IH0_S_T_S D_UW1 IH0_K_S_P_EH1_R_AH0_M_AH0_N_T_S W_IH1_DH AH0 HH_EH1_L_TH IH2_N_T_ER0_V_EH1_N_SH_AH0_N IH0_N AE1_N AH0_T_EH1_M_P_T T_UW1 F_AY1_N_D IH0_N_AH1_F EH1_V_AH0_D_AH0_N_S F_AO1_R AH0 P_R_AA1_S_EH2_S W_IH1_CH W_UH1_D B_IY1 Y_UW1_S_F_AH0_L AE1_Z AH0 M_EH1_D_AH0_K_AH0_L T_R_IY1_T_M_AH0_N_T In DH_AH0 K_EY1_S AH1_V F_AA2_R_M_AH0_S_UW1_T_IH0_K_AH0_L S_T_AH1_D_IY0    DH_AH0 F_EY1_Z_AH0_Z S_T_AA1_R_T W_IH1_DH D_R_AH1_G D_IH0_Z_AY1_N AH0_N_D D_R_AH1_G D_IH0_S_K_AH1_V_ER0_IY0 DH_EH1_N P_R_AH0_S_IY1_D AA1_N T_UW1 AE1_N_AH0_M_AH0_L T_EH1_S_T_IH0_NG If DH_IH1_S IH1_Z S_AH0_K_S_EH1_S_F_AH0_L    DH_EY1 B_IH0_G_IH1_N DH_AH0 K_L_IH1_N_AH0_K_AH0_L F_EY1_Z AH1_V D_IH0_V_EH1_L_AH0_P_M_AH0_N_T B_AY1 T_EH1_S_T_IH0_NG F_AO1_R S_EY1_F_T_IY0 IH0_N AH0 F_Y_UW1 HH_Y_UW1_M_AH0_N S_AH1_B_JH_IH0_K_T_S AH0_N_D IH0_K_S_P_AE1_N_D T_UW1 T_EH1_S_T IH0_N M_EH1_N_IY0 S_T_AH1_D_IY0 P_AA0_R_T_IH1_S_AH0_P_AH0_N_T_S T_UW1 D_AH0_T_ER1_M_AH0_N IH1_F DH_AH0 T_R_IY1_T_M_AH0_N_T IH1_Z IH0_F_EH1_K_T_IH0_V Clinical T_R_AY1_AH0_L_Z IH2_N_V_AA1_L_V_IH0_NG N_UW1 D_R_AH1_G_Z AA1_R K_AA1_M_AH0_N_L_IY0 K_L_AE1_S_AH0_F_AY2_D IH1_N_T_UW0 F_AO1_R F_EY1_Z_AH0_Z Individual T_R_AY1_AH0_L_Z M_EY1 EH0_N_K_AH1_M_P_AH0_S M_AO1_R DH_AE1_N W_AH1_N F_EY1_Z K_AA1_M_AH0_N IH0_G_Z_AE1_M_P_AH0_L AH1_V DH_IH1_S IH1_Z K_AH0_M_B_AY1_N_D F_EY1_Z II AO1_R F_EY1_Z II III T_R_AY1_AH0_L_Z Therefore    IH1_T M_EY1 B_IY1 IY1_Z_IY0_ER0 T_UW1 TH_IH1_NG_K AH1_V ER1_L_IY0 F_EY1_Z S_T_AH1_D_IY0_Z AH0_N_D L_EY1_T F_EY1_Z S_T_AH1_D_IY0_Z     The D_R_AH1_G D_IH0_V_EH1_L_AH0_P_M_AH0_N_T P_R_AA1_S_EH2_S W_IH1_L N_AO1_R_M_AH0_L_IY0 P_R_AH0_S_IY1_D TH_R_UW1 AO1_L F_AO1_R F_EY1_Z_AH0_Z OW1_V_ER0 M_EH1_N_IY0 Y_IH1_R_Z If DH_AH0 D_R_AH1_G S_AH0_K_S_EH1_S_F_AH0_L_IY0 P_AE1_S_AH0_Z TH_R_UW1 Phases    II    AH0_N_D III    IH1_T W_IH1_L Y_UW1_ZH_AH0_W_AH0_L_IY0 B_IY1 AH0_P_R_UW1_V_D B_AY1 DH_AH0 N_AE1_SH_AH0_N_AH0_L R_EH1_G_Y_AH0_L_AH0_T_AO2_R_IY0 AH0_TH_AO1_R_AH0_T_IY0 F_AO1_R Y_UW1_S IH0_N DH_AH0 JH_EH1_N_ER0_AH0_L P_AA2_P_Y_AH0_L_EY1_SH_AH0_N Phase IV AA1_R P_OW1_S_T AH0_P_R_UW1_V_AH0_L S_T_AH1_D_IY0_Z Before F_AA2_R_M_AH0_S_UW1_T_IH0_K_AH0_L K_AH1_M_P_AH0_N_IY2_Z S_T_AA1_R_T K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z AA1_N AH0 D_R_AH1_G    DH_EY1 K_AA1_N_D_AH0_K_T IH0_K_S_T_EH1_N_S_IH0_V P_R_IY1 K_L_IH1_N_AH0_K_AH0_L S_T_AH1_D_IY0_Z These IH2_N_V_AA1_L_V IH0_N V_IH1_T_R_OW0    T_EH1_S_T T_UW1_B AO1_R S_EH1_L K_AH1_L_CH_ER0    AH0_N_D IH0_N V_IY1_V_OW0    AE1_N_AH0_M_AH0_L    IH0_K_S_P_EH1_R_AH0_M_AH0_N_T_S Y_UW1_Z_IH0_NG W_AY1_D R_EY1_N_JH_IH0_NG D_OW1_S_AH0_Z AH1_V DH_AH0 S_T_AH1_D_IY0 D_R_AH1_G T_UW1 AH0_B_T_EY1_N P_R_IH0_L_IH1_M_AH0_N_EH2_R_IY0 EH1_F_IH0_K_AE2_S_IY0    T_AA0_K_S_IH1_S_AH0_T_IY0 AH0_N_D pharmacokinetic IH2_N_F_AO2_R_M_EY1_SH_AH0_N Such T_EH1_S_T_S AH0_S_IH1_S_T F_AA2_R_M_AH0_S_UW1_T_IH0_K_AH0_L K_AH1_M_P_AH0_N_IY2_Z T_UW1 D_IH2_S_AY1_D W_EH1_DH_ER0 AH0 D_R_AH1_G K_AE1_N_D_AH0_D_EY0_T HH_AE1_Z S_AY2_AH0_N_T_IH1_F_IH0_K M_EH1_R_AH0_T F_AO1_R F_ER1_DH_ER0 D_IH0_V_EH1_L_AH0_P_M_AH0_N_T AE1_Z AE1_N IH2_N_V_EH0_S_T_IH0_G_EY1_SH_AH0_N_AH0_L N_UW1 D_R_AH1_G Phase IH1_Z AH0 R_IY1_S_AH0_N_T D_EH2_Z_AH0_G_N_EY1_SH_AH0_N F_AO1_R AA1_P_SH_AH0_N_AH0_L IH0_K_S_P_L_AO1_R_AH0_T_AO2_R_IY0 T_R_AY1_AH0_L_Z K_AH0_N_D_AH1_K_T_AH0_D IH0_N AH0_K_AO1_R_D_AH0_N_S W_IH1_DH DH_AH0 United States Food AH0_N_D Drug Administration EH1_S    FDA    2006 Guidance AA1_N Exploratory Investigational New Drug    IND    Studies    Phase T_R_AY1_AH0_L_Z AA1_R AO1_L_S_OW0 N_OW1_N AE1_Z HH_Y_UW1_M_AH0_N microdosing S_T_AH1_D_IY0_Z AH0_N_D AA1_R D_IH0_Z_AY1_N_D T_UW1 S_P_IY1_D AH1_P DH_AH0 D_IH0_V_EH1_L_AH0_P_M_AH0_N_T AH1_V P_R_AA1_M_AH0_S_IH0_NG D_R_AH1_G_Z AO1_R IH1_M_IH0_JH_IH0_NG EY1_JH_AH0_N_T_S B_AY1 IH0_S_T_AE1_B_L_IH0_SH_IH0_NG V_EH1_R_IY0 ER1_L_IY0 AA1_N W_EH1_DH_ER0 DH_AH0 D_R_AH1_G AO1_R EY1_JH_AH0_N_T B_IH0_HH_EY1_V_Z IH0_N HH_Y_UW1_M_AH0_N S_AH1_B_JH_IH0_K_T_S AE1_Z W_AA1_Z IH0_K_S_P_EH1_K_T_AH0_D F_R_AH1_M P_R_IY0_K_L_IH1_N_IH0_K_AH0_L S_T_AH1_D_IY0_Z Distinctive F_IY1_CH_ER0_Z AH1_V Phase T_R_AY1_AH0_L_Z IH2_N_K_L_UW1_D DH_AH0 AE0_D_M_IH2_N_IH0_S_T_R_EY1_SH_AH0_N AH1_V S_IH1_NG_G_AH0_L subtherapeutic D_OW1_S_AH0_Z AH1_V DH_AH0 S_T_AH1_D_IY0 D_R_AH1_G T_UW1 AH0 S_M_AO1_L N_AH1_M_B_ER0 AH1_V S_AH1_B_JH_IH0_K_T_S    10 T_UW1 15    T_UW1 G_AE1_DH_ER0 P_R_IH0_L_IH1_M_AH0_N_EH2_R_IY0 D_EY1_T_AH0 AA1_N DH_AH0 EY1_JH_AH0_N_T EH1_S    pharmacokinetics    W_AH1_T DH_AH0 B_AA1_D_IY0 D_AH1_Z T_UW1 DH_AH0 D_R_AH1_G_Z    Phase S_T_AH1_D_IY0 G_IH1_V_Z N_OW1 D_EY1_T_AH0 AA1_N S_EY1_F_T_IY0 AO1_R EH1_F_IH0_K_AE2_S_IY0    B_IY1_IH0_NG B_AY1 D_EH2_F_AH0_N_IH1_SH_AH0_N AH0 D_OW1_S T_UW1 L_OW1 T_UW1 K_AA1_Z EH1_N_IY0 TH_EH2_R_AH0_P_Y_UW1_T_IH0_K IH0_F_EH1_K_T Drug D_IH0_V_EH1_L_AH0_P_M_AH0_N_T K_AH1_M_P_AH0_N_IY2_Z K_AE1_R_IY0 AW1_T Phase S_T_AH1_D_IY0_Z T_UW1 R_AE1_NG_K D_R_AH1_G K_AE1_N_D_AH0_D_EY0_T_S IH0_N AO1_R_D_ER0 T_UW1 D_IH2_S_AY1_D W_IH1_CH HH_AE1_Z DH_AH0 B_EH1_S_T pharmacokinetic P_ER0_AE1_M_AH0_T_ER0_Z IH0_N HH_Y_UW1_M_AH0_N_Z T_UW1 T_EY1_K F_AO1_R_W_ER0_D IH1_N_T_UW0 F_ER1_DH_ER0 D_IH0_V_EH1_L_AH0_P_M_AH0_N_T They EH0_N_EY1_B_AH0_L G_OW1 N_OW1 G_OW1 D_IH0_S_IH1_ZH_AH0_N_Z T_UW1 B_IY1 B_EY1_S_T AA1_N R_EH1_L_AH0_V_AH0_N_T HH_Y_UW1_M_AH0_N M_AA1_D_AH0_L_Z IH2_N_S_T_EH1_D AH1_V R_IY0_L_AY1_IH0_NG AA1_N S_AH0_M_T_AY1_M_Z IH2_N_K_AH0_N_S_IH1_S_T_AH0_N_T AE1_N_AH0_M_AH0_L D_EY1_T_AH0 Phase T_R_AY1_AH0_L_Z W_ER1 F_AO1_R_M_ER0_L_IY0 R_AH0_F_ER1_D T_UW1 AE1_Z  “ F_ER1_S_T IH0_N M_AE1_N S_T_AH1_D_IY0_Z ”  B_AH1_T DH_AH0 F_IY1_L_D JH_EH1_N_ER0_AH0_L_IY0 M_UW1_V_D T_UW1 DH_AH0 JH_EH1_N_D_ER0 N_UW1_T_R_AH0_L L_AE1_NG_G_W_AH0_JH F_R_EY1_Z    F_ER1_S_T IH0_N HH_Y_UW1_M_AH0_N_Z    IH0_N DH_AH0 1990s ;   DH_IY1_Z T_R_AY1_AH0_L_Z AA1_R DH_AH0 F_ER1_S_T S_T_EY1_JH AH1_V T_EH1_S_T_IH0_NG IH0_N HH_Y_UW1_M_AH0_N S_AH1_B_JH_IH0_K_T_S    They AA1_R D_IH0_Z_AY1_N_D T_UW1 T_EH1_S_T DH_AH0 S_EY1_F_T_IY0    S_AY1_D IH0_F_EH1_K_T_S    B_EH1_S_T D_OW1_S    AH0_N_D F_AO2_R_M_Y_AH0_L_EY1_SH_AH0_N M_EH1_TH_AH0_D F_AO1_R DH_AH0 D_R_AH1_G    Normally    AH0 S_M_AO1_L G_R_UW1_P AH1_V 100 HH_EH1_L_TH_IY0 V_AA2_L_AH0_N_T_IH1_R_Z W_IH1_L B_IY1 R_IH0_K_R_UW1_T_IH0_D     These T_R_AY1_AH0_L_Z AA1_R AO1_F_T_AH0_N K_AH0_N_D_AH1_K_T_AH0_D IH0_N AH0 K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L K_L_IH1_N_IH0_K    W_EH1_R DH_AH0 S_AH0_B_JH_EH1_K_T K_AE1_N B_IY1 AH0_B_Z_ER1_V_D B_AY1 F_UH1_L T_AY1_M S_T_AE1_F These K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L K_L_IH1_N_IH0_K_S AA1_R AO1_F_T_AH0_N R_AH1_N B_AY1 K_AA1_N_T_R_AE2_K_T R_IY0_S_ER1_CH AO2_R_G_AH0_N_AH0_Z_EY1_SH_AH0_N    CROs    HH_UW1 K_AA1_N_D_AH0_K_T DH_IY1_Z S_T_AH1_D_IY0_Z AA1_N B_IH0_HH_AE1_F AH1_V F_AA2_R_M_AH0_S_UW1_T_IH0_K_AH0_L K_AH1_M_P_AH0_N_IY2_Z AO1_R AH1_DH_ER0 R_IY0_S_ER1_CH IH2_N_V_EH1_S_T_AH0_G_EY2_T_ER0_Z The S_AH0_B_JH_EH1_K_T HH_UW1 R_AH0_S_IY1_V_Z DH_AH0 D_R_AH1_G IH1_Z Y_UW1_ZH_AH0_W_AH0_L_IY0 AH0_B_Z_ER1_V_D AH0_N_T_IH1_L S_EH1_V_ER0_AH0_L HH_AE1_F L_IH1_V_Z AH1_V DH_AH0 D_R_AH1_G HH_AE1_V P_AE1_S_T This F_EY1_Z IH1_Z D_IH0_Z_AY1_N_D T_UW1 AH0_S_EH1_S DH_AH0 S_EY1_F_T_IY0    pharmacovigilance     tolerability    pharmacokinetics    AH0_N_D pharmacodynamics AH1_V AH0 D_R_AH1_G Phase T_R_AY1_AH0_L_Z N_AO1_R_M_AH0_L_IY0 IH2_N_K_L_UW1_D D_OW1_S R_EY1_N_JH_IH0_NG    AO1_L_S_OW0 K_AO1_L_D D_OW1_S EH2_S_K_AH0_L_EY1_SH_AH0_N S_T_AH1_D_IY0_Z    S_OW1 DH_AE1_T DH_AH0 B_EH1_S_T AH0_N_D S_EY1_F_AH0_S_T D_OW1_S K_AE1_N B_IY1 F_AW1_N_D AH0_N_D T_UW1 D_IH0_S_K_AH1_V_ER0 DH_AH0 P_OY1_N_T AE1_T W_IH1_CH AH0 K_AA1_M_P_AW0_N_D IH1_Z T_UW1 P_OY1_Z_AH0_N_AH0_S T_UW1 AH0_D_M_IH1_N_IH0_S_T_ER0    The T_EH1_S_T_IH0_D R_EY1_N_JH AH1_V D_OW1_S_AH0_Z W_IH1_L Y_UW1_ZH_AH0_W_AH0_L_IY0 B_IY1 AH0 F_R_AE1_K_SH_AH0_N K_W_AA1_N_T_IH0_F_AY2    AH1_V DH_AH0 D_OW1_S DH_AE1_T K_AA1_Z_D HH_AA1_R_M IH0_N AE1_N_AH0_M_AH0_L T_EH1_S_T_IH0_NG Phase T_R_AY1_AH0_L_Z M_OW1_S_T AO1_F_T_AH0_N IH2_N_K_L_UW1_D HH_EH1_L_TH_IY0 V_AA2_L_AH0_N_T_IH1_R_Z However    DH_EH1_R AA1_R S_AH1_M S_ER1_K_AH0_M_S_T_AE2_N_S_AH0_Z W_EH1_N K_L_IH1_N_AH0_K_AH0_L P_EY1_SH_AH0_N_T_S AA1_R Y_UW1_Z_D    S_AH1_CH AE1_Z P_EY1_SH_AH0_N_T_S HH_UW1 HH_AE1_V T_ER1_M_AH0_N_AH0_L K_AE1_N_S_ER0 AO1_R HIV AH0_N_D DH_AH0 T_R_IY1_T_M_AH0_N_T IH1_Z L_AY1_K_L_IY0 T_UW1 M_EY1_K HH_EH1_L_TH_IY0 IH2_N_D_AH0_V_IH1_JH_AH0_W_AH0_L_Z IH1_L These S_T_AH1_D_IY0_Z AA1_R Y_UW1_ZH_AH0_W_AH0_L_IY0 K_AH0_N_D_AH1_K_T_AH0_D IH0_N T_AY1_T_L_IY0 K_AH0_N_T_R_OW1_L_D K_L_IH1_N_IH0_K_S K_AO1_L_D CPUs    Central Pharmacological Units     W_EH1_R P_AA0_R_T_IH1_S_AH0_P_AH0_N_T_S R_AH0_S_IY1_V 24 AW1_ER0 M_EH1_D_AH0_K_AH0_L AH0_T_EH1_N_SH_AH0_N AH0_N_D OW1_V_ER0_S_AY2_T In AH0_D_IH1_SH_AH0_N T_UW1 DH_AH0 P_R_IY1_V_IY0_AH0_S_L_IY0 M_EH1_N_SH_AH0_N_D AH0_N_HH_EH1_L_TH_IY0 IH2_N_D_AH0_V_IH1_JH_AH0_W_AH0_L_Z   “ P_EY1_SH_AH0_N_T_S HH_UW1 HH_AE1_V T_IH1_P_IH0_K_L_IY0 AO0_L_R_EH1_D_IY0 T_R_AY1_D AH0_N_D F_EY1_L_D T_UW1 IH2_M_P_R_UW1_V AA1_N DH_AH0 IH0_G_Z_IH1_S_T_IH0_NG S_T_AE1_N_D_ER0_D TH_EH1_R_AH0_P_IY0_Z     M_EY1 AO1_L_S_OW0 P_AA0_R_T_IH1_S_AH0_P_EY2_T IH0_N F_EY1_Z T_R_AY1_AH0_L_Z    Volunteers AA1_R P_EY1_D AH0 V_EH1_R_IY0_AH0_B_AH0_L IH2_N_K_AH0_N_V_IY1_N_Y_AH0_N_S F_IY1 F_AO1_R DH_EH1_R T_AY1_M S_P_EH1_N_T IH0_N DH_AH0 V_AA2_L_AH0_N_T_IH1_R S_EH1_N_T_ER0 Before B_IH0_G_IH1_N_IH0_NG AH0 F_EY1_Z T_R_AY1_AH0_L    DH_AH0 S_P_AA1_N_S_ER0 M_AH1_S_T S_AH0_B_M_IH1_T AE1_N Investigational New Drug AE2_P_L_AH0_K_EY1_SH_AH0_N T_UW1 DH_AH0 FDA D_IH0_T_EY1_L_IH0_NG DH_AH0 P_R_IH0_L_IH1_M_AH0_N_EH2_R_IY0 D_EY1_T_AH0 AA1_N DH_AH0 D_R_AH1_G G_AE1_DH_ER0_D F_R_AH1_M S_EH1_L_Y_AH0_L_ER0 M_AA1_D_AH0_L_Z AH0_N_D AE1_N_AH0_M_AH0_L S_T_AH1_D_IY0_Z Phase T_R_AY1_AH0_L_Z K_AE1_N B_IY1 F_ER1_DH_ER0 D_IH0_V_AY1_D_IH0_D    Once AH0 D_OW1_S AO1_R R_EY1_N_JH AH1_V D_OW1_S_AH0_Z IH1_Z D_IH0_T_ER1_M_AH0_N_D    DH_AH0 N_EH1_K_S_T G_OW1_L IH1_Z T_UW1 IH0_V_AE1_L_Y_UW0_EY2_T W_EH1_DH_ER0 DH_AH0 D_R_AH1_G HH_AE1_Z EH1_N_IY0 B_AY2_AH0_L_AA1_JH_IH0_K_AH0_L AE0_K_T_IH1_V_IH0_T_IY0 AO1_R IH0_F_EH1_K_T     Phase II T_R_AY1_AH0_L_Z AA1_R P_ER0_F_AO1_R_M_D AA1_N L_AA1_R_JH_ER0 G_R_UW1_P_S    100 300    AH0_N_D AA1_R D_IH0_Z_AY1_N_D T_UW1 AH0_S_EH1_S HH_AW1 W_EH1_L DH_AH0 D_R_AH1_G W_ER1_K_S    AE1_Z W_EH1_L AE1_Z T_UW1 K_AH0_N_T_IH1_N_Y_UW0 Phase S_EY1_F_T_IY0 AH0_S_EH1_S_M_AH0_N_T_S IH0_N AH0 L_AA1_R_JH_ER0 G_R_UW1_P AH1_V V_AA2_L_AH0_N_T_IH1_R_Z AH0_N_D P_EY1_SH_AH0_N_T_S    Genetic T_EH1_S_T_IH0_NG IH1_Z K_AA1_M_AH0_N    P_AA2_R_T_IH1_K_Y_AH0_L_ER0_L_IY0 W_EH1_N DH_EH1_R IH1_Z EH1_V_AH0_D_AH0_N_S AH1_V V_EH2_R_IY0_EY1_SH_AH0_N IH0_N M_EH2_T_AH0_B_AA1_L_IH0_K R_EY1_T     When DH_AH0 D_IH0_V_EH1_L_AH0_P_M_AH0_N_T P_R_AA1_S_EH2_S F_AO1_R AH0 N_UW1 D_R_AH1_G F_EY1_L_Z    DH_IH1_S Y_UW1_ZH_AH0_W_AH0_L_IY0 AH0_K_ER1_Z D_UH1_R_IH0_NG Phase II T_R_AY1_AH0_L_Z W_EH1_N DH_AH0 D_R_AH1_G IH1_Z D_IH0_S_K_AH1_V_ER0_D N_AA1_T T_UW1 W_ER1_K AE1_Z P_L_AE1_N_D    AO1_R T_UW1 HH_AE1_V T_AA1_K_S_IH0_K IH0_F_EH1_K_T_S Phase II S_T_AH1_D_IY0_Z AA1_R S_AH0_M_T_AY1_M_Z D_IH0_V_AY1_D_IH0_D IH1_N_T_UW0 Phase IIA AH0_N_D Phase IIB There IH1_Z N_OW1 F_AO1_R_M_AH0_L D_EH2_F_AH0_N_IH1_SH_AH0_N F_AO1_R DH_IY1_Z S_AH1_B K_AE1_T_AH0_G_AO2_R_IY0_Z    B_AH1_T JH_EH1_N_ER0_AH0_L_IY0    Some T_R_AY1_AH0_L_Z K_AA1_M_B_AY0_N Phase AH0_N_D Phase II    AH0_N_D T_EH1_S_T B_OW1_TH EH1_F_IH0_K_AE2_S_IY0 AH0_N_D T_AA0_K_S_IH1_S_AH0_T_IY0 Some R_IY1_S_ER0_CH_ER0_Z AA1_R_G_Y_UW0 DH_AE1_T F_EY1_Z II S_T_AH1_D_IY0_Z AA1_R JH_EH1_N_ER0_AH0_L_IY0 S_M_AO1_L_ER0 DH_AE1_N DH_EY1 AO1_T T_UW1 B_IY1    Phase II K_L_IH1_N_AH0_K_AH0_L P_R_OW1_G_R_AE2_M_Z HH_IH0_S_T_AO1_R_IH0_K_AH0_L_IY0 HH_AE1_V IH0_K_S_P_IH1_R_IY0_AH0_N_S_T DH_AH0 L_OW1_AH0_S_T S_AH0_K_S_EH1_S R_EY1_T AH1_V DH_AH0 F_AO1_R D_IH0_V_EH1_L_AH0_P_M_AH0_N_T F_EY1_Z_AH0_Z    In 2010    DH_AH0 P_ER0_S_EH1_N_T_AH0_JH AH1_V F_EY1_Z II T_R_AY1_AH0_L_Z DH_AE1_T P_R_AH0_S_IY1_D_AH0_D T_UW1 F_EY1_Z III W_AA1_Z 18 %     AH0_N_D OW1_N_L_IY0 30 %  AH1_V D_IH0_V_EH2_L_AH0_P_M_EH1_N_T_AH0_L K_AE1_N_D_AH0_D_EY0_T_S AH0_D_V_AE1_N_S_T F_R_AH1_M Phase II T_UW1 Phase III IH0_N AH0 L_AA1_R_JH S_T_AH1_D_IY0 AH1_V T_R_AY1_AH0_L_Z F_R_AH1_M 2006 2015    This F_EY1_Z IH1_Z D_IH0_Z_AY1_N_D T_UW1 AH0_S_EH1_S DH_AH0 IH0_F_EH1_K_T_IH0_V_N_AH0_S AH1_V DH_AH0 N_UW1 IH2_N_T_ER0_V_EH1_N_SH_AH0_N AH0_N_D    DH_EH1_R_B_AY1    IH1_T_S V_AE1_L_Y_UW0 IH0_N K_L_IH1_N_AH0_K_AH0_L P_R_AE1_K_T_IH0_S     Phase III S_T_AH1_D_IY0_Z AA1_R R_AE1_N_D_AH0_M_AY2_Z_D K_AH0_N_T_R_OW1_L_D M_AH1_L_T_IY0_S_EH2_N_T_ER0 T_R_AY1_AH0_L_Z AA1_N L_AA1_R_JH P_EY1_SH_AH0_N_T G_R_UW1_P_S    300 000 AO1_R M_AO1_R D_IH0_P_EH1_N_D_IH0_NG AH0_P_AA1_N DH_AH0 D_IH0_Z_IY1_Z M_EH1_D_AH0_K_AH0_L K_AH0_N_D_IH1_SH_AH0_N S_T_AH1_D_IY0_D    AH0_N_D AA1_R EY1_M_D AE1_T B_IY1_IH0_NG DH_AH0 D_IH0_F_IH1_N_IH0_T_IH0_V AH0_S_EH1_S_M_AH0_N_T AH1_V HH_AW1 IH0_F_EH1_K_T_IH0_V DH_AH0 D_R_AH1_G IH1_Z    IH0_N K_AH0_M_P_EH1_R_AH0_S_AH0_N W_IH1_DH K_ER1_AH0_N_T G_OW1_L_D S_T_AE1_N_D_ER0_D T_R_IY1_T_M_AH0_N_T Because AH1_V DH_EH1_R S_AY1_Z AH0_N_D K_AH0_M_P_AE1_R_AH0_T_IH0_V_L_IY2 L_AO1_NG D_UH1_R_EY1_SH_AH0_N    Phase III T_R_AY1_AH0_L_Z AA1_R DH_AH0 M_OW1_S_T IH0_K_S_P_EH1_N_S_IH0_V    T_AY1_M K_AH0_N_S_UW1_M_IH0_NG AH0_N_D D_IH1_F_AH0_K_AH0_L_T T_R_AY1_AH0_L_Z T_UW1 D_IH0_Z_AY1_N AH0_N_D R_AH1_N    AH0_S_P_EH1_SH_L_IY0 IH0_N TH_EH1_R_AH0_P_IY0_Z F_AO1_R K_R_AA1_N_IH0_K M_EH1_D_AH0_K_AH0_L K_AH0_N_D_IH1_SH_AH0_N_Z Phase III T_R_AY1_AH0_L_Z AH1_V K_R_AA1_N_IH0_K K_AH0_N_D_IH1_SH_AH0_N_Z AO1_R D_IH0_Z_IY1_Z_AH0_Z AO1_F_T_AH0_N HH_AE1_V AH0 SH_AO1_R_T F_AA1_L_OW0 AH1_P P_IH1_R_IY0_AH0_D F_AO1_R IH0_V_AE2_L_Y_UW0_EY1_SH_AH0_N    R_EH1_L_AH0_T_IH0_V T_UW1 DH_AH0 P_IH1_R_IY0_AH0_D AH1_V T_AY1_M DH_AH0 IH2_N_T_ER0_V_EH1_N_SH_AH0_N M_AY1_T B_IY1 Y_UW1_Z_D IH0_N P_R_AE1_K_T_IH0_S     This IH1_Z S_AH0_M_T_AY1_M_Z K_AO1_L_D DH_AH0    P_R_IY1 M_AA1_R_K_AH0_T_IH0_NG F_EY1_Z    B_IH0_K_AO1_Z IH1_T AE1_K_CH_UW2_AH0_L_IY0 M_EH1_ZH_ER0_Z K_AH0_N_S_UW1_M_ER0 R_IH0_S_P_AA1_N_S T_UW1 DH_AH0 D_R_AH1_G It IH1_Z K_AA1_M_AH0_N P_R_AE1_K_T_IH0_S DH_AE1_T S_ER1_T_AH0_N Phase III T_R_AY1_AH0_L_Z W_IH1_L K_AH0_N_T_IH1_N_Y_UW0 W_AY1_L DH_AH0 R_EH1_G_Y_AH0_L_AH0_T_AO2_R_IY0 S_AH0_B_M_IH1_SH_AH0_N IH1_Z P_EH1_N_D_IH0_NG AE1_T DH_AH0 AH0_P_R_OW1_P_R_IY0_AH0_T R_EH1_G_Y_AH0_L_AH0_T_AO2_R_IY0 EY1_JH_AH0_N_S_IY0 This AH0_L_AW1_Z P_EY1_SH_AH0_N_T_S T_UW1 K_AH0_N_T_IH1_N_Y_UW0 T_UW1 R_AH0_S_IY1_V P_AA1_S_AH0_B_L_IY0 L_AY1_F_S_EY2_V_IH0_NG D_R_AH1_G_Z AH0_N_T_IH1_L DH_AH0 D_R_AH1_G K_AE1_N B_IY1 AH0_B_T_EY1_N_D B_AY1 P_ER1_CH_AH0_S Other R_IY1_Z_AH0_N_Z F_AO1_R P_ER0_F_AO1_R_M_IH0_NG T_R_AY1_AH0_L_Z AE1_T DH_IH1_S S_T_EY1_JH IH2_N_K_L_UW1_D AH0_T_EH1_M_P_T_S B_AY1 DH_AH0 S_P_AA1_N_S_ER0 AE1_T    L_EY1_B_AH0_L IH0_K_S_P_AE1_N_SH_AH0_N     T_UW1 SH_OW1 DH_AH0 D_R_AH1_G W_ER1_K_S F_AO1_R AH0_D_IH1_SH_AH0_N_AH0_L T_AY1_P_S AH1_V P_EY1_SH_AH0_N_T_S D_IH0_Z_IY1_Z_AH0_Z B_IH0_AA1_N_D DH_AH0 ER0_IH1_JH_AH0_N_AH0_L Y_UW1_S F_AO1_R W_IH1_CH DH_AH0 D_R_AH1_G W_AA1_Z AH0_P_R_UW1_V_D F_AO1_R M_AA1_R_K_AH0_T_IH0_NG     T_UW1 AH0_B_T_EY1_N AH0_D_IH1_SH_AH0_N_AH0_L S_EY1_F_T_IY0 D_EY1_T_AH0    AO1_R T_UW1 S_AH0_P_AO1_R_T M_AA1_R_K_AH0_T_IH0_NG K_L_EY1_M_Z F_AO1_R DH_AH0 D_R_AH1_G Studies IH0_N DH_IH1_S F_EY1_Z AA1_R B_AY1 S_AH1_M K_AH1_M_P_AH0_N_IY2_Z K_AE1_T_AH0_G_ER0_AY2_Z_D AE1_Z    Phase IIIB S_T_AH1_D_IY0_Z     While N_AA1_T R_IY0_K_W_AY1_ER0_D IH0_N AO1_L K_EY1_S_AH0_Z    IH1_T IH1_Z T_IH1_P_IH0_K_L_IY0 IH0_K_S_P_EH1_K_T_AH0_D DH_AE1_T DH_EH1_R B_IY1 AE1_T L_IY1_S_T T_UW1 S_AH0_K_S_EH1_S_F_AH0_L Phase III T_R_AY1_AH0_L_Z    D_EH1_M_AH0_N_S_T_R_EY2_T_IH0_NG AH0 D_R_AH1_G EH1_S S_EY1_F_T_IY0 AH0_N_D EH1_F_IH0_K_AE2_S_IY0    IH0_N AO1_R_D_ER0 T_UW1 AH0_B_T_EY1_N AH0_P_R_UW1_V_AH0_L F_R_AH1_M DH_AH0 AH0_P_R_OW1_P_R_IY0_AH0_T R_EH1_G_Y_AH0_L_AH0_T_AO2_R_IY0 EY1_JH_AH0_N_S_IY0_Z S_AH1_CH AE1_Z FDA    USA     AO1_R DH_AH0 EMA    European Union Once AH0 D_R_AH1_G HH_AE1_Z P_R_UW1_V_D S_AE2_T_AH0_S_F_AE1_K_T_R_IY0 AE1_F_T_ER0 Phase III T_R_AY1_AH0_L_Z    DH_AH0 T_R_AY1_AH0_L R_IH0_Z_AH1_L_T_S AA1_R Y_UW1_ZH_AH0_W_AH0_L_IY0 K_AH0_M_B_AY1_N_D IH1_N_T_UW0 AH0 L_AA1_R_JH D_AA1_K_Y_AH0_M_EH0_N_T K_AH0_N_T_EY1_N_IH0_NG AH0 K_AA2_M_P_R_IY0_HH_EH1_N_S_IH0_V D_IH0_S_K_R_IH1_P_SH_AH0_N AH1_V DH_AH0 M_EH1_TH_AH0_D_Z AH0_N_D R_IH0_Z_AH1_L_T_S AH1_V HH_Y_UW1_M_AH0_N AH0_N_D AE1_N_AH0_M_AH0_L S_T_AH1_D_IY0_Z    M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_IH0_NG P_R_AH0_S_IY1_JH_ER0_Z    F_AO2_R_M_Y_AH0_L_EY1_SH_AH0_N D_IH0_T_EY1_L_Z    AH0_N_D SH_EH1_L_F L_AY1_F This K_AH0_L_EH1_K_SH_AH0_N AH1_V IH2_N_F_AO2_R_M_EY1_SH_AH0_N M_EY1_K_S AH1_P DH_AH0    R_EH1_G_Y_AH0_L_AH0_T_AO2_R_IY0 S_AH0_B_M_IH1_SH_AH0_N    DH_AE1_T IH1_Z P_R_AH0_V_AY1_D_AH0_D F_AO1_R R_IY2_V_Y_UW1 T_UW1 DH_AH0 AH0_P_R_OW1_P_R_IY0_AH0_T R_EH1_G_Y_AH0_L_AH0_T_AO2_R_IY0 AH0_TH_AO1_R_AH0_T_IY0_Z    IH0_N D_IH1_F_ER0_AH0_N_T K_AH1_N_T_R_IY0_Z They W_IH1_L R_IY2_V_Y_UW1 DH_AH0 S_AH0_B_M_IH1_SH_AH0_N    AH0_N_D    IH1_T IH1_Z HH_OW1_P_T    G_IH1_V DH_AH0 S_P_AA1_N_S_ER0 AH0_P_R_UW1_V_AH0_L T_UW1 M_AA1_R_K_AH0_T DH_AH0 D_R_AH1_G Most D_R_AH1_G_Z AH2_N_D_ER0_G_OW1_IH0_NG Phase III K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z K_AE1_N B_IY1 M_AA1_R_K_AH0_T_AH0_D AH1_N_D_ER0 FDA N_AO1_R_M_Z W_IH1_DH P_R_AA1_P_ER0 R_EH2_K_AH0_M_AH0_N_D_EY1_SH_AH0_N_Z AH0_N_D G_AY1_D_L_AY2_N_Z TH_R_UW1 AH0 New Drug Application    NDA    K_AH0_N_T_EY1_N_IH0_NG AO1_L M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_IH0_NG    P_R_IY1 K_L_IH1_N_AH0_K_AH0_L    AH0_N_D K_L_IH1_N_AH0_K_AH0_L D_EY1_T_AH0 In K_EY1_S AH1_V EH1_N_IY0 AE0_D_V_ER1_S IH0_F_EH1_K_T_S B_IY1_IH0_NG R_IY2_P_AO1_R_T_AH0_D EH1_N_IY0_W_EH2_R    DH_AH0 D_R_AH1_G_Z N_IY1_D T_UW1 B_IY1 R_IH0_K_AO1_L_D IH2_M_IY1_D_IY2_AH0_T_L_IY0 F_R_AH1_M DH_AH0 M_AA1_R_K_AH0_T    While M_OW1_S_T F_AA2_R_M_AH0_S_UW1_T_IH0_K_AH0_L K_AH1_M_P_AH0_N_IY2_Z R_IH0_F_R_EY1_N F_R_AH1_M DH_IH1_S P_R_AE1_K_T_IH0_S    IH1_T IH1_Z N_AA1_T AE0_B_N_AO1_R_M_AH0_L T_UW1 S_IY1 M_EH1_N_IY0 D_R_AH1_G_Z AH2_N_D_ER0_G_OW1_IH0_NG Phase III K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z IH0_N DH_AH0 M_AA1_R_K_AH0_T    As AH1_V 2010    AH0_B_AW1_T 50 %  AH1_V D_R_AH1_G K_AE1_N_D_AH0_D_EY0_T_S IY1_DH_ER0 F_EY1_L D_UH1_R_IH0_NG DH_AH0 Phase III T_R_AY1_AH0_L AO1_R AA1_R R_IH0_JH_EH1_K_T_IH0_D B_AY1 DH_AH0 N_AE1_SH_AH0_N_AH0_L R_EH1_G_Y_AH0_L_AH0_T_AO2_R_IY0 EY1_JH_AH0_N_S_IY0    Phase II III K_AA1_S_T The AH0_M_AW1_N_T AH1_V M_AH1_N_IY0 S_P_EH1_N_T AA1_N Phase II III T_R_AY1_AH0_L_Z D_IH0_P_EH1_N_D_Z AA1_N N_UW1_M_ER0_AH0_S F_AE1_K_T_ER0_Z    W_IH1_DH TH_EH2_R_AH0_P_Y_UW1_T_IH0_K EH1_R_IY0_AH0 B_IY1_IH0_NG S_T_AH1_D_IY0_D AH0_N_D T_AY1_P_S AH1_V K_L_IH1_N_AH0_K_AH0_L P_R_AH0_S_IY1_JH_ER0_Z AE1_Z K_IY1 D_R_AY1_V_ER0_Z ;  Phase II S_T_AH1_D_IY0_Z M_EY1 K_AA1_S_T AE1_Z M_AH1_CH AE1_Z  $ 20 M_IH1_L_Y_AH0_N    AH0_N_D Phase III AE1_Z M_AH1_CH AE1_Z  $ 53 M_IH1_L_Y_AH0_N    Phase IV T_R_AY1_AH0_L IH1_Z AO1_L_S_OW0 N_OW1_N AE1_Z postmarketing S_ER0_V_EY1_L_AH0_N_S T_R_AY1_AH0_L    AO1_R IH2_N_F_AO1_R_M_AH0_L_IY0 AE1_Z AH0 K_AH0_N_F_ER1_M_AH0_T_AO2_R_IY0 T_R_AY1_AH0_L Phase IV T_R_AY1_AH0_L_Z IH2_N_V_AA1_L_V DH_AH0 S_EY1_F_T_IY0 S_ER0_V_EY1_L_AH0_N_S    pharmacovigilance    AH0_N_D AA1_N_G_OW2_IH0_NG T_EH1_K_N_IH0_K_AH0_L S_AH0_P_AO1_R_T AH1_V AH0 D_R_AH1_G AE1_F_T_ER0 IH1_T R_AH0_S_IY1_V_Z P_ER0_M_IH1_SH_AH0_N T_UW1 B_IY1 S_OW1_L_D    IY1 JH_IY1 AE1_F_T_ER0 AH0_P_R_UW1_V_AH0_L AH1_N_D_ER0 DH_AH0 FDA Accelerated Approval Program    Phase IV S_T_AH1_D_IY0_Z M_EY1 B_IY1 R_IY0_K_W_AY1_ER0_D B_AY1 R_EH1_G_Y_AH0_L_AH0_T_AO2_R_IY0 AH0_TH_AO1_R_AH0_T_IY0_Z AO1_R M_EY1 B_IY1 AH1_N_D_ER0_T_EY2_K_AH0_N B_AY1 DH_AH0 S_P_AA1_N_S_ER0_IH0_NG K_AH1_M_P_AH0_N_IY2 F_AO1_R K_AH0_M_P_EH1_T_AH0_T_IH0_V    F_AY1_N_D_IH0_NG AH0 N_UW1 M_AA1_R_K_AH0_T F_AO1_R DH_AH0 D_R_AH1_G    AO1_R AH1_DH_ER0 R_IY1_Z_AH0_N_Z    F_AO1_R IH0_G_Z_AE1_M_P_AH0_L    DH_AH0 D_R_AH1_G M_EY1 N_AA1_T HH_AE1_V B_IH1_N T_EH1_S_T_IH0_D F_AO1_R IH2_N_T_ER0_AE1_K_SH_AH0_N_Z W_IH1_DH AH1_DH_ER0 D_R_AH1_G_Z    AO1_R AA1_N S_ER1_T_AH0_N P_AA2_P_Y_AH0_L_EY1_SH_AH0_N G_R_UW1_P_S S_AH1_CH AE1_Z P_R_EH1_G_N_AH0_N_T W_IH1_M_AH0_N    HH_UW1 AA1_R AH0_N_L_AY1_K_L_IY0 T_UW1 S_AH0_B_JH_EH1_K_T DH_EH0_M_S_EH1_L_V_Z T_UW1 T_R_AY1_AH0_L_Z     The S_EY1_F_T_IY0 S_ER0_V_EY1_L_AH0_N_S IH1_Z D_IH0_Z_AY1_N_D T_UW1 D_IH0_T_EH1_K_T EH1_N_IY0 R_EH1_R AO1_R L_AO1_NG T_ER1_M AE0_D_V_ER1_S IH0_F_EH1_K_T_S OW1_V_ER0 AH0 M_AH1_CH L_AA1_R_JH_ER0 P_EY1_SH_AH0_N_T P_AA2_P_Y_AH0_L_EY1_SH_AH0_N AH0_N_D L_AO1_NG_G_ER0 T_AY1_M P_IH1_R_IY0_AH0_D DH_AE1_N W_AA1_Z P_AA1_S_AH0_B_AH0_L D_UH1_R_IH0_NG DH_AH0 Phase III K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z     Harmful IH0_F_EH1_K_T_S D_IH0_S_K_AH1_V_ER0_D B_AY1 Phase IV T_R_AY1_AH0_L_Z M_EY1 R_IH0_Z_AH1_L_T IH0_N AH0 D_R_AH1_G B_IY1_IH0_NG N_OW1 L_AO1_NG_G_ER0 S_OW1_L_D    AO1_R R_IY0_S_T_R_IH1_K_T_AH0_D T_UW1 S_ER1_T_AH0_N Y_UW1_S_AH0_Z ;  R_IY1_S_AH0_N_T IH0_G_Z_AE1_M_P_AH0_L_Z IH2_N_V_AA1_L_V cerivastatin    B_R_AE1_N_D N_EY1_M_Z Baycol AH0_N_D Lipobay     troglitazone    Rezulin    AH0_N_D rofecoxib    Vioxx The M_IH1_N_AH0_M_AH0_M T_AY1_M P_IH1_R_IY0_AH0_D M_AE1_N_D_AH0_T_AO2_R_IY0 F_AO1_R Phase IV K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z IH1_Z Y_IH1_R_Z    The IH0_N_T_AY1_ER0 P_R_AA1_S_EH2_S AH1_V D_IH0_V_EH1_L_AH0_P_IH0_NG AH0 D_R_AH1_G F_R_AH1_M P_R_IY0_K_L_IH1_N_IH0_K_AH0_L R_IY0_S_ER1_CH T_UW1 M_AA1_R_K_AH0_T_IH0_NG K_AE1_N T_EY1_K AH0_P_R_AA1_K_S_AH0_M_AH0_T_L_IY0 12 T_UW1 18 Y_IH1_R_Z AH0_N_D AO1_F_T_AH0_N K_AA1_S_T_S W_EH1_L OW1_V_ER0  $ B_IH1_L_Y_AH0_N    